Obesity Surgery最新文献_第4页

Dumping Syndrome After One Anastomosis Gastric Bypass-A Systematic Review. 一次胃分流术后倾倒综合征的系统评价

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-04-17 DOI: 10.1007/s11695-025-07860-2

Mohammad Kermansaravi, Masoumeh Shahsavan, Bassem Amr, Christine Stier, Chetan Parmar, Sonja Chiappetta

引用次数: 0

Are We Over-Blaming Metabolic and Bariatric Surgery for Gallbladder Diseases It Did Not Cause? The Impact of Preoperative Ultrasound Practices. 我们是否过分指责代谢和减肥手术导致了并非由它引起的胆囊疾病？术前超声检查的影响。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-04-16 DOI: 10.1007/s11695-025-07868-8

Mohamed Hany, Nour Zayed, Mohamed H Zidan

引用次数: 0

Early Exercise Boosts Visceral Fat Loss Post-Bariatric Surgery in the First Month. 早期运动促进减肥手术后第一个月的内脏脂肪减少。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-05-05 DOI: 10.1007/s11695-025-07791-y

Yuheng Liu, Huajun Bai

引用次数: 0

Post OAGB Reflux: Strengthening Evidence-Based Surveillance. OAGB后反流：加强循证监测。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 DOI: 10.1007/s11695-025-07959-6

Ahmed Talha, Aya Bessa, Zeyad Ahmed Talha, Mohamed Ragab, Marwan Abdou

引用次数: 0

Indications and Outcomes of Laparoscopic Versus Robotic Conversional Bariatric Surgery: An MBSAQIP Study. 腹腔镜与机器人减肥手术的适应症和结果：一项MBSAQIP研究。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-05-07 DOI: 10.1007/s11695-025-07886-6

Juan S Barajas-Gamboa, Mohammed Sakib Ihsan Khan, Kevin Zhan, Thomas H Shin, Valentin Mocanu, Gustavo Romero-Velez, Andrew T Strong, Salvador Navarrete, Carlos Abril, Juan Pablo Pantoja, A Daniel Guerron, John Rodriguez, Ricard Corcelles, Matthew Kroh, Jerry T Dang

{"title":"Indications and Outcomes of Laparoscopic Versus Robotic Conversional Bariatric Surgery: An MBSAQIP Study.","authors":"Juan S Barajas-Gamboa, Mohammed Sakib Ihsan Khan, Kevin Zhan, Thomas H Shin, Valentin Mocanu, Gustavo Romero-Velez, Andrew T Strong, Salvador Navarrete, Carlos Abril, Juan Pablo Pantoja, A Daniel Guerron, John Rodriguez, Ricard Corcelles, Matthew Kroh, Jerry T Dang","doi":"10.1007/s11695-025-07886-6","DOIUrl":"10.1007/s11695-025-07886-6","url":null,"abstract":"Background: Conversional bariatric surgeries (CBS) are performed using laparoscopic and robotic techniques, but comprehensive data comparing these approaches remains scarce.Objective: To compare the indications and outcomes of laparoscopic versus robotic CBS.Methods: The MBSAQIP database was retrospectively analyzed from 2020 to 2022, comparing laparoscopic and robotic CBS. Primary outcomes were 30-day serious complications and mortality.Results: Of 72,189 CBS procedures, 75.4% were laparoscopic and 24.6% robotic. Mean age and BMI were similar between groups. The most common indications for both approaches were reflux, weight regain, and inadequate weight loss, with reflux being more prevalent in robotic CBS (38.3% vs 33.2%). Sleeve-to-bypass was the most common procedure in both groups (35.8% laparoscopic, 44.2% robotic). Robotic CBS had longer mean operative times (165.4 vs 121.7 min, p < 0.001) and slightly longer hospital stays (1.7 vs 1.6 days, p < 0.001). The rate of serious complications was slightly higher for robotic CBS, though not statistically significant (6.5% vs 6.1%, p = 0.08). Robotic CBS had higher rates of leak (0.9% vs 0.7%, p = 0.071), reoperation (2.8% vs 2.6%, p = 0.138), and readmission (6.7% vs 5.4%, p < 0.001). Mortality rates were similar (0.1% for both, p = 0.942).Conclusions: Both laparoscopic and robotic CBS show similar safety profiles with comparable mortality rates. However, robotic CBS was associated with longer operative times, slightly longer hospital stays, and higher readmission rates. These findings suggest that the choice between approaches should consider individual patient factors and institutional expertise.","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"2191-2201"},"PeriodicalIF":2.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12130091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144010061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Disease-Based Criteria vs BMI Level for Prioritization of Metabolic Surgery. 基于疾病的标准与BMI水平对代谢手术优先级的影响。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-05-17 DOI: 10.1007/s11695-025-07896-4

Pia Roser, Robert D McIntyre, Simone Cremona, Adel Assiri, Lyz Bezerra Silva, Ghassan Chamseddine, Francesco Rubino

{"title":"Disease-Based Criteria vs BMI Level for Prioritization of Metabolic Surgery.","authors":"Pia Roser, Robert D McIntyre, Simone Cremona, Adel Assiri, Lyz Bezerra Silva, Ghassan Chamseddine, Francesco Rubino","doi":"10.1007/s11695-025-07896-4","DOIUrl":"10.1007/s11695-025-07896-4","url":null,"abstract":"Background: BMI is widely used as a primary criterion for prioritizing candidates for metabolic surgery. However, it may not fully capture disease severity or mortality risks associated with comorbidities such as type 2 diabetes (T2D) and cardiovascular disease (CVD). This study aimed to assess whether BMI accurately reflects disease burden and risk in patients undergoing metabolic surgery.Methods: A retrospective audit included 723 adult candidates for primary metabolic surgery at a tertiary care center between January 2014 and December 2022. Patients undergoing revisional surgeries were excluded. Clinical data, including demographics, comorbidities, and disease severity indicators (e.g., ASA score, Charlson Comorbidity Index [CCI], medication usage, and estimated 10-year survival), were analyzed. Patients were grouped by BMI (< or ≥ 50 kg/m2), T2D, and CVD status for comparison.Results: Prevalence rates for T2D, BMI ≥ 50 kg/m2, and CVD were 41.6%, 37.3%, and 16.2%, respectively. Patients with BMI ≥ 50 kg/m2 were generally younger, had fewer comorbidities, lower CVD prevalence, and better estimated 10-year survival than those with BMI < 50 kg/m2. In contrast, patients with T2D and CVD had significantly higher ASA and CCI scores, greater medication usage, and reduced 10-year survival (p < 0.001 for T2D; p < 0.01 for CVD).Conclusion: Higher BMI levels do not reflect greater disease burden and mortality risk among candidates for bariatric/metabolic surgery. These findings do not support the use of high BMI-based thresholds (e.g., ≥ 50 kg/m2) as criteria for expedited access. Clinically relevant measures of baseline disease burden should be used to determine the urgency of access to surgical treatment of obesity and T2D.","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"2081-2091"},"PeriodicalIF":2.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12130112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Outcomes of Bariatric Surgery in Patients With Bipolar and Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis. 双相情感障碍和精神分裂症谱系障碍患者减肥手术的结果：系统回顾和荟萃分析。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-04-28 DOI: 10.1007/s11695-025-07889-3

Túlio Pimentel, Maria Clara Florêncio, Ivo Queiroz, Mariano Gallo Ruelas, Roberta De Lorenzi Steiger Ferraz, Álvaro Antônio Bandeira Ferraz

{"title":"Outcomes of Bariatric Surgery in Patients With Bipolar and Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.","authors":"Túlio Pimentel, Maria Clara Florêncio, Ivo Queiroz, Mariano Gallo Ruelas, Roberta De Lorenzi Steiger Ferraz, Álvaro Antônio Bandeira Ferraz","doi":"10.1007/s11695-025-07889-3","DOIUrl":"10.1007/s11695-025-07889-3","url":null,"abstract":"Psychiatric disorders, particularly bipolar disorder (BD) and schizophrenia spectrum disorders (SCZ), are associated with high rates of obesity and metabolic diseases. This systematic review and meta-analysis evaluates the efficacy of bariatric surgery in BD/SCZ patients, aiming to inform clinical decisions and optimize treatment strategies for this population. MEDLINE, Embase, and Cochrane databases were searched up to September 2024. A restricted maximum likelihood random-effects model with mean differences (MD) for continuous outcomes and odds ratios (ORs) for binary outcomes, along with 95% confidence intervals (CI), was used. 13 studies involving 19,662 patients, of whom 1,117 (5.7%) were diagnosed with BD or SCZ, were included. The analysis revealed no significant differences in %TWL or BMI change at 6 months, 1 year, and 2 years. BD/SCZ patients showed a significantly smaller %EWL at 6 months; however, the differences at 1 and 2 years were no longer statistically significant. Similarly, no differences were found between BD/SCZ patients and controls regarding adherence to 6-month, 1-year, and 2-year follow-up, as well as 1-year remission rates of type 2 diabetes mellitus, hypertension, obstructive sleep apnea syndrome, dyslipidemia, or 30-day readmission and reoperation rates. Data from included studies also indicated no exacerbation of psychiatric disorders after surgery. This study suggests that bariatric surgery may be similarly effective in patients with BD and SCZ, offering potential benefits for a population burdened with both psychiatric and physical health challenges.","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"2352-2369"},"PeriodicalIF":2.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reframing Obesity: Physiological Mechanisms, Clinical Diagnosis, and Implications for Metabolic Bariatric Surgery. 重塑肥胖：生理机制、临床诊断和代谢性减肥手术的意义。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 DOI: 10.1007/s11695-025-07870-0

Bart Torensma, Mohamed Hany, Edo Aarts, Frits Berends, Bart van Wagensveld, Chetan Parmar, Scott Shikora, Ricardo V Cohen

引用次数: 0

Endoscopic Sleeve Gastroplasty for the Treatment of Metabolic Syndrome: A Systematic Review and Meta-analysis. 治疗代谢综合征的内镜袖状胃成形术：系统回顾与元分析》。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-04-08 DOI: 10.1007/s11695-025-07842-4

Mark Hanscom, Muhammad Usman Baig, Drew Wright, Laith Baqain, Kate Elise Johnson, Vivek Kumbhari, Shelby Sullivan, Barham Abu Dayyeh, SriHari Mahadev, Carolyn Newberry, Kartik Sampath, David Carr-Locke, Christopher Thompson, Reem Sharaiha

{"title":"Endoscopic Sleeve Gastroplasty for the Treatment of Metabolic Syndrome: A Systematic Review and Meta-analysis.","authors":"Mark Hanscom, Muhammad Usman Baig, Drew Wright, Laith Baqain, Kate Elise Johnson, Vivek Kumbhari, Shelby Sullivan, Barham Abu Dayyeh, SriHari Mahadev, Carolyn Newberry, Kartik Sampath, David Carr-Locke, Christopher Thompson, Reem Sharaiha","doi":"10.1007/s11695-025-07842-4","DOIUrl":"10.1007/s11695-025-07842-4","url":null,"abstract":"Background: Endoscopic sleeve gastroplasty (ESG) is an incisionless weight loss procedure that has been demonstrated to be safe and effective for the treatment of obesity; however, the efficacy of ESG for the treatment of comorbid type 2 diabetes mellitus (T2DM) and other components of metabolic syndrome (MetS) has been less well studied. We aimed to conduct a systematic review and meta-analysis of available literature to evaluate the outcomes of ESG on T2DM and MetS.Methods: Bibliographic databases were systematically searched for studies assessing the outcomes of ESG on T2DM and MetS. Studies were included if they reported at least one objective outcome related to T2DM or other components of MetS, including hyperlipidemia (HLD), hypertriglyceridemia, and hypertension (HTN). This study was deemed IRB exempt.Results: Ten studies with 4320 patients were included. At 12 months, ESG was associated with significant improvements in T2DM, HLD, and HTN, with risk difference of - 0.72 [95% CI, - 0.87 to - 0.58, p < 0.00001], - 0.65 [95% CI, - 0.78 to - 0.52, p < 0.00001], and - 0.60 [95% CI, - 0.66 to - 0.53, p < 0.00001], respectively. Disease improvement was defined as patients being able to stop some or all of their related treatment medications. Additionally, there were significant reductions in hemoglobin A1c (HGBA1c), fasting blood glucose, homeostatic model assessment for insulin resistance (HOMA-IR), low-density lipoprotein, and triglycerides.Conclusions: ESG is an effective modality for the treatment of comorbid T2DM and MetS in patients with obesity. Additional studies are needed to establish long-term responses and to compare ESG against established pharmacologic and surgical techniques.","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"2092-2100"},"PeriodicalIF":2.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Critical Considerations for AI in Bariatric Surgery: Interpretability, Transparency, and Adaptability. 人工智能在减肥手术中的关键考虑因素：可解释性、透明度和适应性。

IF 2.9 3区医学

Obesity Surgery Pub Date : 2025-06-01 Epub Date: 2025-05-15 DOI: 10.1007/s11695-025-07925-2

Weijia Qin, Ru He

引用次数: 0